Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor

被引:15
|
作者
Stojanov, Ivan J. [1 ,2 ]
Marino-Enriquez, Adrian [3 ,4 ]
Bahri, Nacef [3 ,4 ]
Jo, Vickie Y. [3 ,4 ]
Woo, Sook-Bin [5 ,6 ]
机构
[1] Case Western Reserve Univ, Sch Dent Med, Dept Oral & Maxillofacial Med & Diagnost Sci, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[3] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
[5] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA USA
[6] StrataDx, Ctr Oral Pathol, Lexington, MA USA
来源
HEAD & NECK PATHOLOGY | 2019年 / 13卷 / 02期
关键词
Lipoma; Atypical lipomatous tumor; Liposarcoma; Well-differentiated liposarcoma; Immunohistochemistry; FISH; WELL-DIFFERENTIATED LIPOSARCOMA; ANISOMETRIC CELL LIPOMA; GENE; EXPRESSION; NEOPLASMS; DIAGNOSIS; SUBTYPES; REGION;
D O I
10.1007/s12105-018-0928-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Traumatized lipomas with degenerative change may demonstrate histopathologic features that mimic atypical lipomatous tumor (ALT). Previously reported series of ALT involving the oral cavity preceded routine use of MDM2 and CDK4 immunohistochemistry. Our aim is to evaluate MDM2 and CDK4 immunohistochemical expression in adipocytic tumors arising in this site, in conjunction with the histiocytic marker PU.1, to determine whether MDM2 and CDK4 impacts classification. 17 cases originally diagnosed as ALT were retrieved and immunohistochemical studies for MDM2, CDK4 and PU.1 were performed. FISH analysis for MDM2 amplification was performed in select cases. For this study group, the male:female ratio was 9:8 and the median age was 62 (range 41-88). All 17 cases presented as well- or predominantly well-circumscribed proliferations of variably sized, mature adipocytes exhibiting uni- or multi-vacuolation with occasional scalloped nuclei and mild nuclear atypia. Variable amounts of fibrous stroma with focal myxoid change and bland spindle cells were identified in 14/17 cases. Lipoblasts or atypical hyperchromatic stromal cells were not identified in any cases. 14 of 17 cases were negative for MDM2 and CDK4 in tumor cells and 11 of these 14 showed weak nuclear positivity for MDM2 in histiocytes. 3 of 17 cases showed weak, multifocal immunohistochemical expression of MDM2 and CDK4. PU.1 highlighted histiocytes in all 17 cases. FISH analysis for MDM2 amplification was negative in all 3 cases with weak MDM2/CDK4 expression. All cases were reclassified as lipoma with degenerative changes. ALT, in all likelihood, is less common than previously thought in this anatomic location and best diagnosed with ancillary studies. MDM2 expression in histiocytes is best interpreted in conjunction with CDK4 immunohistochemistry and confirmatory FISH for MDM2 amplification.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [41] MDM2 and CDK4 Immunohistochemistry Is Inadequate in the Diagnosis of Problematic Low-Grade Lipomatous Tumors: A Follow-Up Study
    Clay, Michael
    Martinez, Anthony
    Edgar, Mark A.
    LABORATORY INVESTIGATION, 2016, 96 : 16A - 16A
  • [42] MDM2 and CDK4 Immunohistochemistry Is Inadequate in the Diagnosis of Problematic Low-Grade Lipomatous Tumors: A Follow-Up Study
    Clay, Michael
    Martinez, Anthony
    Edgar, Mark A.
    MODERN PATHOLOGY, 2016, 29 : 16A - 16A
  • [43] Evaluation of MDM2 and CDK4 gene amplification and expression as potential tools for the diagnosis of atypical lipomatous tumors/well-differentiated liposarcomas in paraffin-embedded material
    Pauwels, Patrick
    Meulemans, Els V.
    Ruland, Andrea M.
    Debiec-Rychter, Maria
    Sciot, Raf
    Speel, Ernst-Jan M.
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Correlating MDM2 and CDK4 Amplification Levels in Dedifferentiated Liposarcoma (DDLS) with Tumor Behavior and Patient Outcome
    Liu, Y.
    Ricciotti, R.
    Hoch, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S30 - S30
  • [45] IMP3, CDK4, MDM2 and β-catenin expression in Enchondroma and Central Chondrosarcoma: Diagnostic and prognostic utility
    Losada, Daniele Moraes
    Etchebehere, Mauricio
    Cintra, Francisco Fontes
    Amstalden, Eliane Maria Ingrid
    CLINICS, 2024, 79
  • [46] CDK4 inhibition diminishes p53 activation by MDM2 antagonists
    Sriraman, Anusha
    Dickmanns, Antje
    Najafova, Zeynab
    Johnsen, Steven A.
    Dobbelstein, Matthias
    CELL DEATH & DISEASE, 2018, 9
  • [47] MDM2, CDK4 and EGFR1 in intimal sarcomas of pulmonary artery
    Centeno Haro, M.
    Ortega Salas, R.
    Sanchez Sanchez, R.
    Medina Perez, M.
    VIRCHOWS ARCHIV, 2015, 467 : S111 - S111
  • [48] Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification
    Lyle, Pamela L.
    Bridge, Julia A.
    Simpson, Jean F.
    Cates, Justin M.
    Sanders, Melinda E.
    HISTOPATHOLOGY, 2016, 68 (07) : 1040 - 1045
  • [49] Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma
    Avallone, G.
    Roccabianca, P.
    Crippa, L.
    Lepri, E.
    Brunetti, B.
    Bernardini, C.
    Forni, M.
    Olandese, A.
    Sarli, G.
    VETERINARY PATHOLOGY, 2016, 53 (04) : 773 - 780
  • [50] CDK4 inhibition diminishes p53 activation by MDM2 antagonists
    Anusha Sriraman
    Antje Dickmanns
    Zeynab Najafova
    Steven A. Johnsen
    Matthias Dobbelstein
    Cell Death & Disease, 9